Year: 2021

Intellia Therapeutics Announces Expansion of Ongoing Phase 1 Study of NTLA-2001 to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

Approved protocol amendment enables enrollment of ATTR-CM patients in the ongoing first-in-human study of NTLA-2001, a systemically delivered CRISPR/Cas9-based therapyCAMBRIDGE,...

Connecticut Health Technology Company Detect, Inc. Unveils New PCR-quality Covid-19 Rapid Test to Help Meet the Nation’s Testing Needs for Home, School, Work and Travel

Connecticut Governor Ned Lamont, U.S. Senator Richard Blumenthal, U.S. Congresswoman Rosa DeLauro and Lt. Governor Susan Bysiewicz Visit Dr. Jonathan...

error: Content is protected !!